Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia

INTRODUCTION: Fibroblast growth factor 23 (FGF23) is secreted from bone and suppresses the absorption of phosphorus in renal proximal tubule and in intestinal tract. Therefore, the increase of serum FGF23 levels leads to hypophosphatemic situations. Tumor-induced osteomalacia is often induced by var...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Springerplus
Main Authors: Tatsumi, Fuminori, Horiya, Megumi, Tanabe, Akihito, Nishioka, Momoyo, Fushimi, Yoshiro, Sanada, Junpei, Hirata, Yurie, Irie, Shintaro, Kinoshita, Tomoe, Kamei, Shinji, Shimoda, Masashi, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2016
Assuntos:
Case Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093104/
https://ncbi.nlm.nih.gov/pubmed/27867811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-3602-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados